XML 50 R33.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Consolidated Schedule of Investments - Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
--- | --- | --- | ---
Investments at cost |  | $ 759,182 | $ 721,248 |
Investments at fair value |  | 709,085 | 720,026 |
Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 716,077 | 721,248 |
Investments at fair value |  | 693,730 | 720,026 |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | 692,345 | 701,074 |
Investments at fair value |  | 664,203 | 686,458 |
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |  |  |
Investments at cost |  | 6,132 | 4,184 |
Investments at fair value |  | 4,733 | 2,556 |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost |  | 16,400 | 14,790 |
Investments at fair value |  | 24,594 | 29,712 |
Investment, Unaffiliated Issuer [Member] | Other Long-Term Investments [Member] |  |  |  |
Investments at cost |  |  | 1,200 |
Investments at fair value |  |  | 1,300 |
Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 28,677 | 0 |
Investments at fair value |  | 1,132 | 0 | $ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member] |  |  |  |
Investments at fair value |  | 1,000 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member] |  |  |  |
Investments at cost |  | 126 |  |
Investments at fair value |  | 0 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] |  |  |  |
Investments at fair value |  | 0 | 0 |
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member] |  |  |  |
Investments at fair value | [1] | 0 | 0 |
Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | 14,428 | 0 |
Investments at fair value |  | 14,223 | 0 | $ 0
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] |  |  |  |
Investments at fair value |  | 6,230 | 0 |
Biotechnology Sector [Member] |  |  |  |
Investments at cost |  | 145,544 | 193,372 |
Investments at fair value |  | $ 117,781 | $ 195,006 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.25% | 12.50% |
Margin |  | 4.75% | 6.05% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,979 | 4,891 |
Investments at fair value |  | $ 4,979 | $ 4,891 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.25% | 12.50% |
Margin |  | 4.75% | 6.05% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,979 | 4,963 |
Investments at fair value |  | 4,979 | 4,963 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 214 | 214 |
Investments at fair value |  | $ 318 | $ 335 |
Number of Shares (in shares) |  | 7,404 | 7,404 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  |  | $ 250 |
Investments at fair value |  |  | $ 250 |
Number of Shares (in shares) |  |  | 1,162 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.25% | 12.50% |
Margin |  | 4.75% | 6.05% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 3,000 | $ 3,000 |
Investments at cost |  | 2,987 | 2,978 |
Investments at fair value |  | $ 2,987 | $ 2,978 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 13.25% | 12.50% |
Margin |  | 4.75% | 6.05% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,979 | 4,963 |
Investments at fair value |  | $ 4,979 | $ 4,963 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 13.25% | 12.50% |
Margin |  | 4.75% | 6.05% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,979 | 4,963 |
Investments at fair value |  | $ 4,979 | $ 4,963 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 13.25% | 12.50% |
Margin |  | 4.75% | 6.05% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 3,000 | $ 3,000 |
Investments at cost |  | 2,987 | 2,978 |
Investments at fair value |  | 2,987 | $ 2,978 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 4.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.25% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 10,000 |
Investments at cost |  |  | 9,872 |
Investments at fair value |  |  | $ 9,872 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 4.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.25% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 15,000 |
Investments at cost |  |  | 14,808 |
Investments at fair value |  |  | 14,808 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 126 |
Investments at fair value |  |  | $ 125 |
Number of Shares (in shares) |  |  | 463,915 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 4.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.25% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 6,000 |
Investments at cost |  |  | 5,923 |
Investments at fair value |  |  | $ 5,923 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 4.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.25% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 6,000 |
Investments at cost |  |  | 5,923 |
Investments at fair value |  |  | $ 5,923 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 4.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.25% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 4,000 |
Investments at cost |  |  | 3,949 |
Investments at fair value |  |  | $ 3,949 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 4.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.25% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 4,000 |
Investments at cost |  |  | 3,949 |
Investments at fair value |  |  | $ 3,949 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jan. 01, 2025 |
Principal Amount |  |  | $ 2,885 |
Investments at cost |  |  | 2,853 |
Investments at fair value |  |  | $ 2,777 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jan. 01, 2025 |
Principal Amount |  |  | $ 2,885 |
Investments at cost |  |  | 2,823 |
Investments at fair value |  |  | 2,750 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 311 | 311 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 117 | 26,442 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jan. 01, 2025 |
Principal Amount |  |  | $ 1,442 |
Investments at cost |  |  | 1,411 |
Investments at fair value |  |  | $ 1,374 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Feb. 01, 2025 |
Principal Amount |  |  | $ 2,885 |
Investments at cost |  |  | 2,821 |
Investments at fair value |  |  | $ 2,748 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Feb. 01, 2025 |
Principal Amount |  |  | $ 2,885 |
Investments at cost |  |  | 2,821 |
Investments at fair value |  |  | $ 2,748 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Apr. 01, 2025 |
Principal Amount |  |  | $ 1,442 |
Investments at cost |  |  | 1,408 |
Investments at fair value |  |  | $ 1,371 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Apr. 01, 2025 |
Principal Amount |  |  | $ 1,442 |
Investments at cost |  |  | 1,408 |
Investments at fair value |  |  | 1,371 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.22% |  |
Margin |  | 4.72% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jun. 01, 2024 |  |
Principal Amount |  | $ 1,414 |  |
Investments at cost |  | 1,410 |  |
Investments at fair value |  | $ 1,410 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.22% |  |
Margin |  | 4.72% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jun. 01, 2024 |  |
Principal Amount |  | $ 1,414 |  |
Investments at cost |  | 1,410 |  |
Investments at fair value |  | 1,410 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 178 | 176 |
Investments at fair value |  | $ 246 | $ 263 |
Number of Shares (in shares) |  | 110,402 | 110,402 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  |  | $ 356 |
Investments at fair value |  |  | $ 356 |
Number of Shares (in shares) |  |  | 32,831 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.22% |  |
Margin |  | 4.72% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Nov. 01, 2025 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,950 |  |
Investments at fair value |  | $ 4,950 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, LIBOR Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.07% |
Margin |  |  | 7.90% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jun. 01, 2024 |
Principal Amount |  |  | $ 1,979 |
Investments at cost |  |  | 1,962 |
Investments at fair value |  |  | $ 1,962 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 13.22% |  |
Margin |  | 4.72% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | May 01, 2026 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,949 |  |
Investments at fair value |  | 4,949 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |  |
Cash Rate |  |  | 12.07% |
Margin |  |  | 7.90% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jun. 01, 2024 |
Principal Amount |  |  | $ 1,979 |
Investments at cost |  |  | 1,963 |
Investments at fair value |  |  | $ 1,963 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |  |
Cash Rate |  |  | 12.07% |
Margin |  |  | 7.90% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Nov. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,923 |
Investments at fair value |  |  | $ 4,923 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, LIBOR Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.07% |
Margin |  |  | 7.90% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | May 01, 2026 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,912 |
Investments at fair value |  |  | 4,912 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Corvium, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 53 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 661,956 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Imunon, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 65 | $ 66 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 19,671 | 16,502 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.25% | 12.25% |
Margin |  | 4.75% | 4.75% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2027 | May 01, 2027 |
Principal Amount |  | $ 6,250 | $ 6,250 |
Investments at cost |  | 6,199 | 6,077 |
Investments at fair value |  | $ 6,199 | $ 6,077 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.25% | 12.25% |
Margin |  | 4.75% | 4.75% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2027 | May 01, 2027 |
Principal Amount |  | $ 6,250 | $ 6,250 |
Investments at cost |  | 6,199 | 6,177 |
Investments at fair value |  | 6,199 | 6,177 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 50 | 51 |
Investments at fair value |  | $ 53 | $ 60 |
Number of Shares (in shares) |  | 48,076 | 48,077 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mustang Bio, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 146 | $ 146 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 16,611 | 252,161 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Apr. 01, 2025 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,476 |
Investments at fair value |  |  | $ 2,476 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jul. 01, 2025 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,473 |
Investments at fair value |  |  | 2,473 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 35 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 21,120 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.75% | 12.75% |
Margin |  | 5.25% | 5.25% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Nov. 01, 2026 | Nov. 01, 2026 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,716 | 3,630 |
Investments at fair value |  | $ 3,716 | $ 3,630 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.75% | 12.75% |
Margin |  | 5.25% | 5.25% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Nov. 01, 2026 | Nov. 01, 2026 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,478 | 2,469 |
Investments at fair value |  | 2,478 | 2,469 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 64 | 64 |
Investments at fair value |  | $ 157 | $ 162 |
Number of Shares (in shares) |  | 103,679 | 103,679 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2025 | Jul. 01, 2025 |
Principal Amount |  | $ 3,000 | $ 5,000 |
Investments at cost |  | 2,914 | 4,857 |
Investments at fair value |  | $ 2,870 | $ 4,857 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2025 | Jul. 01, 2025 |
Principal Amount |  | $ 1,500 | $ 2,500 |
Investments at cost |  | 1,458 | 2,430 |
Investments at fair value |  | $ 1,436 | 2,430 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 366 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 47,452 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.75% | 3.75% |
Maturity Date |  | Sep. 01, 2026 | Sep. 01, 2026 |
Principal Amount |  | $ 10,000 | $ 10,000 |
Investments at cost |  | 9,911 | 9,701 |
Investments at fair value |  | $ 9,911 | $ 9,701 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.75% | 3.75% |
Maturity Date |  | Sep. 01, 2026 | Sep. 01, 2026 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,717 | 3,697 |
Investments at fair value |  | 3,717 | 3,697 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 160 | 160 |
Investments at fair value |  | $ 606 | $ 3,024 |
Number of Shares (in shares) |  | 299,848 | 299,848 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.75% | 3.75% |
Maturity Date |  | Sep. 01, 2026 | Sep. 01, 2026 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,717 | 3,697 |
Investments at fair value |  | $ 3,717 | 3,697 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.86% |  |
Margin |  | 5.36% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.50% |  |
Maturity Date |  | Dec. 01, 2024 |  |
Principal Amount |  | $ 4,666 |  |
Investments at cost |  | 4,579 |  |
Investments at fair value |  | $ 4,414 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.86% |  |
Margin |  | 5.36% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.50% |  |
Maturity Date |  | Dec. 01, 2024 |  |
Principal Amount |  | $ 4,666 |  |
Investments at cost |  | 4,579 |  |
Investments at fair value |  | 4,414 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 278 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 175,098 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 312 | 399 |
Investments at fair value |  | $ 225 | $ 648 |
Number of Shares (in shares) |  | 691,895 | 203,017 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.86% |  |
Margin |  | 5.36% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.50% |  |
Maturity Date |  | Dec. 01, 2024 |  |
Principal Amount |  | $ 2,333 |  |
Investments at cost |  | 2,281 |  |
Investments at fair value |  | $ 2,199 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, LIBOR Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.67% |
Margin |  |  | 8.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Dec. 01, 2024 |
Principal Amount |  |  | $ 4,667 |
Investments at cost |  |  | 4,597 |
Investments at fair value |  |  | $ 4,597 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 13.86% |  |
Margin |  | 5.36% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.50% |  |
Maturity Date |  | Dec. 01, 2024 |  |
Principal Amount |  | $ 2,333 |  |
Investments at cost |  | 2,281 |  |
Investments at fair value |  | $ 2,199 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |  |
Cash Rate |  |  | 12.67% |
Margin |  |  | 8.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Dec. 01, 2024 |
Principal Amount |  |  | $ 4,667 |
Investments at cost |  |  | 4,597 |
Investments at fair value |  |  | $ 4,597 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 13.86% |  |
Margin |  | 5.36% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.50% |  |
Maturity Date |  | Dec. 01, 2024 |  |
Principal Amount |  | $ 2,333 |  |
Investments at cost |  | 2,278 |  |
Investments at fair value |  | $ 2,196 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |  |
Cash Rate |  |  | 12.67% |
Margin |  |  | 8.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Dec. 01, 2024 |
Principal Amount |  |  | $ 2,333 |
Investments at cost |  |  | 2,280 |
Investments at fair value |  |  | $ 2,280 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 13.86% |  |
Margin |  | 5.36% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.50% |  |
Maturity Date |  | Dec. 01, 2024 |  |
Principal Amount |  | $ 2,333 |  |
Investments at cost |  | 2,278 |  |
Investments at fair value |  | $ 2,196 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, LIBOR Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.67% |
Margin |  |  | 8.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Dec. 01, 2024 |
Principal Amount |  |  | $ 2,333 |
Investments at cost |  |  | 2,280 |
Investments at fair value |  |  | $ 2,280 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, LIBOR Index, Five [Member] |  |  |  |
Cash Rate |  |  | 12.67% |
Margin |  |  | 8.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Dec. 01, 2024 |
Principal Amount |  |  | $ 2,333 |
Investments at cost |  |  | 2,274 |
Investments at fair value |  |  | $ 2,274 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Term Loan, LIBOR Index, Six [Member] |  |  |  |
Cash Rate |  |  | 12.67% |
Margin |  |  | 8.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Dec. 01, 2024 |
Principal Amount |  |  | $ 2,333 |
Investments at cost |  |  | 2,274 |
Investments at fair value |  |  | $ 2,274 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jul. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,946 |
Investments at fair value |  |  | $ 4,946 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jul. 01, 2025 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,473 |
Investments at fair value |  |  | 2,473 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 67 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 39,774 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jan. 01, 2026 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,947 |
Investments at fair value |  |  | $ 4,947 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jan. 01, 2026 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,947 |
Investments at fair value |  |  | $ 4,947 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 8.75% | 8.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 6.00% | 6.00% |
Maturity Date |  | Oct. 01, 2025 | Oct. 01, 2025 |
Principal Amount |  | $ 4,250 | $ 5,000 |
Investments at cost |  | 4,193 | 4,914 |
Investments at fair value |  | $ 4,193 | $ 4,914 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 8.75% | 8.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 6.00% | 6.00% |
Maturity Date |  | Oct. 01, 2025 | Oct. 01, 2025 |
Principal Amount |  | $ 2,125 | $ 2,500 |
Investments at cost |  | 2,096 | 2,457 |
Investments at fair value |  | 2,096 | 2,457 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 264 | 264 |
Investments at fair value |  | $ 113 | $ 37 |
Number of Shares (in shares) |  | 318,181 | 318,181 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Aug. 01, 2027 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,230 |  |
Investments at fair value |  | $ 2,230 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Aug. 01, 2027 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,459 |  |
Investments at fair value |  | 2,459 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 194 |  |
Investments at fair value |  | $ 172 |  |
Number of Shares (in shares) |  | 1,600,002 |  |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Xeris Pharmaceuticals, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 72 | $ 72 |
Investments at fair value |  | $ 33 | $ 3 |
Number of Shares (in shares) |  | 126,000 | 126,000 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Rocket Pharmaceuticals Corporation [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 17 |
Investments at fair value |  |  | $ 14 |
Number of Shares (in shares) |  |  | 7,051 |
Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | vTv Therapeutics Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 44 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 95,293 |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.27% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 5,532 |  |
Investments at cost |  | 5,228 |  |
Investments at fair value |  | $ 222 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.27% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 8,298 |  |
Investments at cost |  | 7,867 |  |
Investments at fair value |  | 336 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | 5,000 |  |
Investments at fair value |  | $ 132 |  |
Number of Shares (in shares) |  | 2,164,502 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.27% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 3,319 |  |
Investments at cost |  | 3,137 |  |
Investments at fair value |  | $ 133 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.27% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 3,319 |  |
Investments at cost |  | 3,137 |  |
Investments at fair value |  | $ 133 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.27% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 2,213 |  |
Investments at cost |  | 2,091 |  |
Investments at fair value |  | 88 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Warrant [Member] |  |  |  |
Investments at cost |  | 126 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 23,196 |  |
Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.27% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 2,213 |  |
Investments at cost |  | 2,091 |  |
Investments at fair value |  | 88 |  |
Medical Device Sector [Member] |  |  |  |
Investments at cost |  | 147,064 | $ 132,803 |
Investments at fair value |  | $ 145,019 | $ 135,960 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 10.25% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Nov. 01, 2026 | Nov. 01, 2026 |
Principal Amount |  | $ 3,500 | $ 3,500 |
Investments at cost |  | 3,469 | 3,360 |
Investments at fair value |  | $ 1,574 | $ 3,360 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 10.25% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Nov. 01, 2026 | Nov. 01, 2026 |
Principal Amount |  | $ 3,500 | $ 3,500 |
Investments at cost |  | 3,563 | 3,460 |
Investments at fair value |  | $ 1,617 | 3,460 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 16 |
Investments at fair value |  |  | $ 16 |
Number of Shares (in shares) |  |  | 86,066 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Corinth Medtech, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.25% |
Margin |  |  | 5.25% |
Floor |  |  | 8.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 20.00% |
Maturity Date |  |  | Sep. 15, 2022 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,500 |
Investments at fair value |  |  | $ 2,500 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Corinth Medtech, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.25% |
Margin |  |  | 5.25% |
Floor |  |  | 8.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 20.00% |
Maturity Date |  |  | Sep. 15, 2022 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,500 |
Investments at fair value |  |  | $ 2,500 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.25% | 11.75% |
Margin |  | 4.75% | 4.75% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Jan. 01, 2027 | Jan. 01, 2027 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,722 | 3,597 |
Investments at fair value |  | $ 3,722 | $ 3,597 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.25% | 11.75% |
Margin |  | 4.75% | 4.75% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Jan. 01, 2027 | Jan. 01, 2027 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,722 | 3,706 |
Investments at fair value |  | 3,722 | 3,706 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 103 | 40 |
Investments at fair value |  | $ 215 | $ 46 |
Number of Shares (in shares) |  | 34,410 | 19,662 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 5.25% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jan. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,943 |  |
Investments at fair value |  | $ 4,943 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 5.25% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jan. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,900 |  |
Investments at fair value |  | $ 4,900 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.59% |  |
Margin |  | 5.09% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jan. 01, 2024 |  |
Principal Amount |  | $ 500 |  |
Investments at cost |  | 500 |  |
Investments at fair value |  | $ 500 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.59% |  |
Margin |  | 5.09% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jan. 01, 2024 |  |
Principal Amount |  | $ 33 |  |
Investments at cost |  | 33 |  |
Investments at fair value |  | 33 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 174 | $ 153 |
Investments at fair value |  | $ 124 | $ 150 |
Number of Shares (in shares) |  | 3,341,376 | 1,375,727 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.59% |  |
Margin |  | 5.09% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Mar. 01, 2024 |  |
Principal Amount |  | $ 800 |  |
Investments at cost |  | 794 |  |
Investments at fair value |  | $ 794 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, LIBOR Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.37% |
Margin |  |  | 8.20% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jan. 01, 2024 |
Principal Amount |  |  | $ 1,625 |
Investments at cost |  |  | 1,610 |
Investments at fair value |  |  | $ 1,610 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |  |
Cash Rate |  |  | 12.37% |
Margin |  |  | 8.20% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jan. 01, 2024 |
Principal Amount |  |  | $ 108 |
Investments at cost |  |  | 107 |
Investments at fair value |  |  | $ 107 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |  |
Cash Rate |  |  | 12.37% |
Margin |  |  | 8.20% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Mar. 01, 2024 |
Principal Amount |  |  | $ 2,000 |
Investments at cost |  |  | 1,983 |
Investments at fair value |  |  | $ 1,983 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Embody, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 28.00% |
Maturity Date |  |  | Aug. 01, 2026 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,482 |
Investments at fair value |  |  | $ 2,482 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.00% | 13.50% |
Margin |  | 3.50% | 6.50% |
Floor |  | 11.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 8.00% | 8.00% |
Maturity Date |  | Sep. 01, 2027 | Jun. 01, 2025 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,297 | 2,476 |
Investments at fair value |  | $ 2,297 | $ 2,476 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.00% | 13.50% |
Margin |  | 3.50% | 6.50% |
Floor |  | 11.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 8.00% | 8.00% |
Maturity Date |  | Sep. 01, 2027 | Jun. 01, 2025 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,473 | 2,476 |
Investments at fair value |  | 2,473 | 2,476 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 275 | 98 |
Investments at fair value |  | $ 269 | $ 123 |
Number of Shares (in shares) |  | 2,637,043 | 605,313 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.00% | 13.50% |
Margin |  | 3.50% | 6.50% |
Floor |  | 11.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 8.00% | 8.00% |
Maturity Date |  | Sep. 01, 2027 | Jun. 01, 2025 |
Principal Amount |  | $ 5,000 | $ 2,500 |
Investments at cost |  | 4,946 | 2,476 |
Investments at fair value |  | $ 4,946 | $ 2,476 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.00% | 13.50% |
Margin |  | 3.50% | 6.50% |
Floor |  | 11.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 8.00% | 8.00% |
Maturity Date |  | Sep. 01, 2027 | Apr. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 2,500 |
Investments at cost |  | 4,946 | 2,453 |
Investments at fair value |  | 4,946 | $ 2,453 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 13.50% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 8.00% |
Maturity Date |  |  | May 01, 2026 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,455 |
Investments at fair value |  |  | $ 2,455 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2024 |
Principal Amount |  |  | $ 3,208 |
Investments at cost |  |  | 3,143 |
Investments at fair value |  |  | $ 3,143 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jun. 01, 2025 |
Principal Amount |  |  | $ 1,000 |
Investments at cost |  |  | 974 |
Investments at fair value |  |  | 974 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 124 | 124 |
Investments at fair value |  | $ 26 | $ 113 |
Number of Shares (in shares) |  | 2,010,424 | 317,647 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 5.00% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Mar. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,939 |
Investments at fair value |  |  | $ 4,939 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 5.00% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Mar. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,939 |
Investments at fair value |  |  | 4,939 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 194 | 194 |
Investments at fair value |  | $ 368 | $ 385 |
Number of Shares (in shares) |  | 809,931 | 809,931 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 5.00% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Mar. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,933 |
Investments at fair value |  |  | $ 4,933 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 5.00% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Mar. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,933 |
Investments at fair value |  |  | $ 4,933 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 12.50% |
Margin |  |  | 5.00% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jan. 01, 2027 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,913 |
Investments at fair value |  |  | $ 4,913 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 12.50% |
Margin |  |  | 5.00% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jan. 01, 2027 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,913 |
Investments at fair value |  |  | $ 4,913 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.50% | 14.50% |
Margin |  | 7.00% | 7.00% |
Floor |  | 10.25% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 1.00% | 1.00% |
Maturity Date |  | Oct. 01, 2025 | Oct. 01, 2025 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,978 | 4,966 |
Investments at fair value |  | $ 4,978 | $ 4,966 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 15.50% | 14.50% |
Margin |  | 7.00% | 7.00% |
Floor |  | 10.25% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 1.00% | 1.00% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,489 | 2,481 |
Investments at fair value |  | $ 2,489 | 2,481 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  |  | 2,000 |
Investments at fair value |  |  | $ 1,700 |
Number of Shares (in shares) |  |  | 392,651 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost |  |  | $ 1,200 |
Investments at fair value |  |  | $ 1,100 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.75% | 12.25% |
Margin |  | 5.25% | 5.25% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 3,500 | $ 3,500 |
Investments at cost |  | 3,467 | 3,349 |
Investments at fair value |  | $ 3,467 | $ 3,349 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.75% | 12.25% |
Margin |  | 5.25% | 5.25% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 3,500 | $ 3,500 |
Investments at cost |  | 3,467 | 3,454 |
Investments at fair value |  | 3,467 | 3,454 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 71 | 71 |
Investments at fair value |  | $ 1 | $ 83 |
Number of Shares (in shares) |  | 135,484 | 135,484 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 5.25% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jul. 01, 2027 |  |
Principal Amount |  | $ 3,500 |  |
Investments at cost |  | 3,456 |  |
Investments at fair value |  | $ 3,456 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 5.25% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jul. 01, 2027 |  |
Principal Amount |  | $ 3,500 |  |
Investments at cost |  | 3,456 |  |
Investments at fair value |  | 3,456 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | ZetrOZ, Inc [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost |  |  | $ 0 |
Investments at fair value |  |  | 200 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | AccuVein Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 24 | 24 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 1,175 | 1,175 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerin Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 66 | $ 64 |
Investments at fair value |  | $ 1,199 | $ 1,200 |
Number of Shares (in shares) |  | 1,818,183 | 1,818,183 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 15,000 |  |
Investments at cost |  | 14,675 |  |
Investments at fair value |  | $ 14,675 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 10,000 |  |
Investments at cost |  | 9,784 |  |
Investments at fair value |  | 9,784 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 432 | $ 53 |
Investments at fair value |  | $ 379 | $ 1 |
Number of Shares (in shares) |  | 4,109 | 408 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,892 |  |
Investments at fair value |  | $ 4,892 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,446 |  |
Investments at fair value |  | 2,446 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 6.00% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,463 |
Investments at fair value |  |  | $ 2,364 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 6.00% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,463 |
Investments at fair value |  |  | 2,364 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 48 | 48 |
Investments at fair value |  | $ 9 | $ 31 |
Number of Shares (in shares) |  | 8,800 | 27,330 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index One [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,468 |  |
Investments at fair value |  | $ 2,342 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,468 |  |
Investments at fair value |  | $ 2,342 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Three [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Jun. 30, 2024 |  |
Principal Amount |  | $ 200 |  |
Investments at cost |  | 200 |  |
Investments at fair value |  | 190 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 7.00% |
Maturity Date |  |  | Nov. 01, 2024 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,475 |
Investments at fair value |  |  | $ 2,475 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 7.00% |
Maturity Date |  |  | Nov. 01, 2024 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,489 |
Investments at fair value |  |  | 2,489 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 86 | 84 |
Investments at fair value |  | $ 1,305 | $ 1,864 |
Number of Shares (in shares) |  | 12,153 | 12,153 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 7.00% |
Maturity Date |  |  | Nov. 01, 2024 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,473 |
Investments at fair value |  |  | $ 2,473 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Sep. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,757 |  |
Investments at fair value |  | $ 4,757 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Sep. 01, 2027 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,454 |  |
Investments at fair value |  | 2,454 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 152 |  |
Investments at fair value |  | $ 135 |  |
Number of Shares (in shares) |  | 93,336 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Sep. 01, 2027 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,454 |  |
Investments at fair value |  | $ 2,454 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.00% | 10.50% |
Margin |  | 3.50% | 3.50% |
Floor |  | 8.25% | 8.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | Oct. 01, 2024 | Oct. 01, 2024 |
Principal Amount |  | $ 3,750 | $ 5,000 |
Investments at cost |  | 3,738 | 4,973 |
Investments at fair value |  | $ 3,738 | $ 4,973 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.00% | 10.50% |
Margin |  | 3.50% | 3.50% |
Floor |  | 8.25% | 8.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | Oct. 01, 2024 | Oct. 01, 2024 |
Principal Amount |  | $ 3,750 | $ 5,000 |
Investments at cost |  | 3,738 | 4,973 |
Investments at fair value |  | 3,738 | 4,973 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 69 | 69 |
Investments at fair value |  | $ 229 | $ 209 |
Number of Shares (in shares) |  | 145,483 | 145,483 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.00% | 10.50% |
Margin |  | 3.50% | 3.50% |
Floor |  | 8.25% | 8.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | Oct. 01, 2024 | Oct. 01, 2024 |
Principal Amount |  | $ 1,875 | $ 2,500 |
Investments at cost |  | 1,866 | 2,478 |
Investments at fair value |  | $ 1,866 | $ 2,478 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.00% | 10.50% |
Margin |  | 3.50% | 3.50% |
Floor |  | 8.25% | 8.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | Oct. 01, 2024 | Oct. 01, 2024 |
Principal Amount |  | $ 1,875 | $ 2,500 |
Investments at cost |  | 1,866 | 2,478 |
Investments at fair value |  | $ 1,866 | $ 2,478 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 8.75% | 8.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 6.00% | 6.00% |
Maturity Date |  | Aug. 01, 2026 | Aug. 01, 2026 |
Principal Amount |  | $ 4,583 | $ 2,500 |
Investments at cost |  | 4,546 | 2,466 |
Investments at fair value |  | $ 4,546 | $ 2,466 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 8.75% | 8.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 6.00% | 6.00% |
Maturity Date |  | Aug. 01, 2026 | Aug. 01, 2026 |
Principal Amount |  | $ 2,292 | $ 5,000 |
Investments at cost |  | 2,273 | 4,932 |
Investments at fair value |  | 2,273 | 4,932 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 149 | 148 |
Investments at fair value |  | $ 167 | $ 179 |
Number of Shares (in shares) |  | 4,106,174 | 775,000 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.32% |  |
Margin |  | 4.82% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 10.36% |  |
Maturity Date |  | Jul. 01, 2025 |  |
Principal Amount |  | $ 3,960 |  |
Investments at cost |  | 3,923 |  |
Investments at fair value |  | $ 3,923 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.32% |  |
Margin |  | 4.82% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 10.36% |  |
Maturity Date |  | Jul. 01, 2025 |  |
Principal Amount |  | $ 3,960 |  |
Investments at cost |  | 3,923 |  |
Investments at fair value |  | 3,923 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 221 | $ 221 |
Investments at fair value |  | $ 206 | $ 226 |
Number of Shares (in shares) |  | 7,972,222 | 7,972,222 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, LIBOR Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.17% |
Margin |  |  | 8.00% |
Floor |  |  | 9.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 10.36% |
Maturity Date |  |  | Jul. 01, 2025 |
Principal Amount |  |  | $ 3,960 |
Investments at cost |  |  | 3,898 |
Investments at fair value |  |  | $ 3,898 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |  |
Cash Rate |  |  | 12.17% |
Margin |  |  | 8.00% |
Floor |  |  | 9.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 10.36% |
Maturity Date |  |  | Jul. 01, 2025 |
Principal Amount |  |  | $ 3,960 |
Investments at cost |  |  | 3,898 |
Investments at fair value |  |  | 3,898 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | CVRx, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 76 | 76 |
Investments at fair value |  | $ 980 | $ 394 |
Number of Shares (in shares) |  | 47,410 | 47,410 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Meditrina, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 83 | $ 83 |
Investments at fair value |  | $ 93 | $ 101 |
Number of Shares (in shares) |  | 233,993 | 233,993 |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,689 |  |
Investments at fair value |  | $ 3,689 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,689 |  |
Investments at fair value |  | 3,689 |  |
Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | MicroTransponder, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 47 |  |
Investments at fair value |  | $ 47 |  |
Number of Shares (in shares) |  | 103,172 |  |
Medical Device Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | $ 0 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 660,537 |  |
Communications Sector [Member] |  |  |  |
Investments at cost |  | $ 19,192 | $ 22,892 |
Investments at fair value |  | $ 22,188 | $ 26,176 |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.50% | 13.00% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Jun. 01, 2026 | Jun. 01, 2026 |
Principal Amount |  | $ 6,250 | $ 7,500 |
Investments at cost |  | 6,218 | 7,455 |
Investments at fair value |  | $ 6,218 | $ 7,455 |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.50% | 13.00% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Jun. 01, 2026 | Jun. 01, 2026 |
Principal Amount |  | $ 6,250 | $ 7,500 |
Investments at cost |  | 6,218 | 7,455 |
Investments at fair value |  | 6,218 | 7,455 |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 47 | 46 |
Investments at fair value |  | $ 61 | $ 67 |
Number of Shares (in shares) |  | 1,991 | 1,991 |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.50% | 13.00% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Jun. 01, 2026 | Jun. 01, 2026 |
Principal Amount |  | $ 6,250 | $ 7,500 |
Investments at cost |  | 6,218 | 7,455 |
Investments at fair value |  | 6,218 | $ 7,455 |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost |  | 261 |  |
Investments at fair value |  | $ 306 |  |
Number of Shares (in shares) |  | 1,810 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Convertible Debt Securities [Member] |  |  |  |
Cash Rate |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2023 |
Principal Amount |  |  | $ 250 |
Investments at cost |  |  | 250 |
Investments at fair value |  |  | 306 |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Intelepeer Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 138 | 139 |
Investments at fair value |  | $ 3,036 | $ 3,265 |
Number of Shares (in shares) |  | 2,936,535 | 2,936,535 |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | PebblePost, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 92 | $ 92 |
Investments at fair value |  | $ 131 | $ 173 |
Number of Shares (in shares) |  | 598,850 | 598,850 |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost |  | $ 89 |  |
Investments at fair value |  | $ 89 |  |
Number of Shares (in shares) |  | 2,688,971 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost |  | $ 2,800 |  |
Investments at fair value |  | $ 1,281 |  |
Number of Shares (in shares) |  | 280,000 |  |
Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost |  | $ 4 |  |
Investments at fair value |  | $ 193 |  |
Number of Shares (in shares) |  | 66,127 |  |
Software Sector [Member] |  |  |  |
Investments at cost |  | $ 164,133 | $ 120,157 |
Investments at fair value |  | $ 160,749 | $ 118,716 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.00% | 14.00% |
Margin |  | 6.50% | 6.50% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.50% | 3.50% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 6,625 | $ 6,500 |
Investments at cost |  | 6,519 | 6,347 |
Investments at fair value |  | $ 6,176 | $ 6,347 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 15.00% | 14.00% |
Margin |  | 6.50% | 6.50% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.50% | 3.50% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 6,116 | $ 6,000 |
Investments at cost |  | 6,018 | 5,859 |
Investments at fair value |  | 5,701 | 5,859 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 455 | 455 |
Investments at fair value |  | $ 46 | $ 197 |
Number of Shares (in shares) |  | 516,732 | 516,732 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 15.00% | 14.00% |
Margin |  | 6.50% | 6.50% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.50% | 3.50% |
Maturity Date |  | Aug. 01, 2026 | Aug. 01, 2026 |
Principal Amount |  | $ 2,548 | $ 2,500 |
Investments at cost |  | 2,507 | 2,436 |
Investments at fair value |  | $ 2,375 | $ 2,436 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.75% | 13.25% |
Margin |  | 6.25% | 6.25% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.50% | 4.50% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,728 | 3,678 |
Investments at fair value |  | $ 3,728 | $ 3,678 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.75% | 13.25% |
Margin |  | 6.25% | 6.25% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.50% | 4.50% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,728 | 3,718 |
Investments at fair value |  | $ 3,728 | $ 3,718 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 10.25% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 10,000 | $ 10,000 |
Investments at cost |  | 9,895 | 9,826 |
Investments at fair value |  | $ 9,895 | $ 9,826 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 10.25% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 10,000 | $ 10,000 |
Investments at cost |  | 9,895 | 9,826 |
Investments at fair value |  | 9,895 | 9,826 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 273 | 273 |
Investments at fair value |  | $ 13 | $ 296 |
Number of Shares (in shares) |  | 639,918 | 639,918 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 10.25% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,947 | 4,913 |
Investments at fair value |  | $ 4,947 | $ 4,913 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 10.25% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,947 | 4,913 |
Investments at fair value |  | $ 4,947 | $ 4,913 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.00% | 14.00% |
Margin |  | 6.50% | 6.50% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Mar. 01, 2026 | Mar. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,971 | 4,947 |
Investments at fair value |  | $ 4,971 | $ 4,947 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 15.00% | 14.00% |
Margin |  | 6.50% | 6.50% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Mar. 01, 2026 | Mar. 01, 2026 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,486 | 2,474 |
Investments at fair value |  | 2,486 | 2,474 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 32 | 34 |
Investments at fair value |  | $ 120 | $ 41 |
Number of Shares (in shares) |  | 101,308 | 101,308 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.50% | 13.00% |
Margin |  | 6.00% | 6.00% |
Floor |  | 14.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 3.00% |
Maturity Date |  | Nov. 01, 2026 | Jul. 01, 2025 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,471 | 2,396 |
Investments at fair value |  | $ 2,373 | $ 2,396 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.50% | 13.00% |
Margin |  | 6.00% | 6.00% |
Floor |  | 14.25% | 12.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 3.00% |
Maturity Date |  | Dec. 01, 2026 | Dec. 01, 2026 |
Principal Amount |  | $ 1,250 | $ 1,250 |
Investments at cost |  | 1,237 | 1,231 |
Investments at fair value |  | 1,188 | 1,231 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 43 | 40 |
Investments at fair value |  | $ 1 | $ 44 |
Number of Shares (in shares) |  | 85,543 | 80,197 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.50% |  |
Margin |  | 6.00% |  |
Floor |  | 14.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Apr. 01, 2027 |  |
Principal Amount |  | $ 1,000 |  |
Investments at cost |  | 994 |  |
Investments at fair value |  | $ 954 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,779 |  |
Investments at fair value |  | $ 4,779 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,915 |  |
Investments at fair value |  | 4,915 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 223 |  |
Investments at fair value |  | $ 247 |  |
Number of Shares (in shares) |  | 948,275 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,915 |  |
Investments at fair value |  | $ 4,915 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,915 |  |
Investments at fair value |  | $ 4,915 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount |  | $ 10,000 |  |
Investments at cost |  | 9,885 |  |
Investments at fair value |  | $ 9,885 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,942 |  |
Investments at fair value |  | 4,942 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 115 |  |
Investments at fair value |  | $ 2 |  |
Number of Shares (in shares) |  | 84,037 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,942 |  |
Investments at fair value |  | $ 4,942 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.75% | 14.25% |
Margin |  | 7.25% | 7.25% |
Floor |  | 10.50% | 10.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Aug. 01, 2025 | Aug. 01, 2025 |
Principal Amount |  | $ 3,667 | $ 5,000 |
Investments at cost |  | 3,625 | 4,932 |
Investments at fair value |  | 3,625 | 4,932 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 56 | 56 |
Investments at fair value |  | $ 80 | $ 39 |
Number of Shares (in shares) |  | 3,731 | 3,731 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Aug. 01, 2026 | Aug. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,959 | 4,870 |
Investments at fair value |  | $ 4,959 | $ 4,870 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Aug. 01, 2026 | Aug. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,959 | 4,933 |
Investments at fair value |  | 4,959 | 4,933 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 123 | 123 |
Investments at fair value |  | $ 135 | $ 133 |
Number of Shares (in shares) |  | 309,208 | 309,208 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Aug. 01, 2026 | Aug. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,959 | 4,933 |
Investments at fair value |  | $ 4,959 | $ 4,933 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 14.25% | 13.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Aug. 01, 2026 | Aug. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,959 | 4,933 |
Investments at fair value |  | 4,959 | $ 4,933 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 16.93% |
Margin |  |  | 9.43% |
Floor |  |  | 12.68% |
Ceiling |  |  | 0.00% |
ETP |  |  | 50.43% |
Maturity Date |  |  | Dec. 31, 2022 |
Principal Amount |  |  | $ 3,295 |
Investments at cost |  |  | 3,295 |
Investments at fair value |  |  | 3,295 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 46 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 82,967 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Equity Securities [Member] |  |  |  |
Investments at cost |  |  | $ 230 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 72,638,663 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 18 | $ 22 |
Investments at fair value |  | $ 42 | $ 312 |
Number of Shares (in shares) |  | 71,305 | 288,115 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.75% | 13.50% |
Margin |  | 4.25% | 6.50% |
Floor |  | 12.00% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 4.00% |
Maturity Date |  | Jun. 01, 2028 | Feb. 01, 2025 |
Principal Amount |  | $ 2,500 | $ 3,500 |
Investments at cost |  | 2,457 | 3,472 |
Investments at fair value |  | $ 2,457 | $ 3,472 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.75% | 13.50% |
Margin |  | 4.25% | 6.50% |
Floor |  | 12.00% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 4.00% |
Maturity Date |  | Jun. 01, 2028 | Feb. 01, 2025 |
Principal Amount |  | $ 3,500 | $ 3,500 |
Investments at cost |  | 3,489 | 3,472 |
Investments at fair value |  | 3,489 | $ 3,472 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 64 |  |
Investments at fair value |  | $ 135 |  |
Number of Shares (in shares) |  | 682 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.75% | 13.50% |
Margin |  | 4.25% | 6.50% |
Floor |  | 12.00% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 4.00% |
Maturity Date |  | Jun. 01, 2028 | Dec. 01, 2025 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,492 | 2,472 |
Investments at fair value |  | $ 2,492 | $ 2,472 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.75% | 13.50% |
Margin |  | 4.25% | 6.50% |
Floor |  | 12.00% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 4.00% |
Maturity Date |  | Jun. 01, 2028 | Dec. 01, 2025 |
Principal Amount |  | $ 1,500 | $ 2,500 |
Investments at cost |  | 1,495 | 2,472 |
Investments at fair value |  | $ 1,495 | $ 2,472 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.75% |
Margin |  | 5.50% | 6.75% |
Floor |  | 14.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 5.00% |
Maturity Date |  | Oct. 01, 2028 | Mar. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 2,500 |
Investments at cost |  | 4,860 | 2,421 |
Investments at fair value |  | $ 4,860 | $ 2,421 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.75% |
Margin |  | 5.50% | 6.75% |
Floor |  | 14.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 5.00% |
Maturity Date |  | Oct. 01, 2028 | Mar. 01, 2026 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,466 | 2,487 |
Investments at fair value |  | 2,466 | 2,487 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 98 | 21 |
Investments at fair value |  | $ 174 | $ 69 |
Number of Shares (in shares) |  | 161,215 | 77,828 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 14.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,466 |  |
Investments at fair value |  | $ 2,466 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 14.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,466 |  |
Investments at fair value |  | $ 2,466 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 4.00% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,773 |  |
Investments at fair value |  | $ 4,773 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 4.00% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,467 |  |
Investments at fair value |  | 2,467 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 120 |  |
Investments at fair value |  | $ 105 |  |
Number of Shares (in shares) |  | 345,443 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 4.00% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 2,500 |  |
Investments at cost |  | 2,467 |  |
Investments at fair value |  | 2,467 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | E La Carte, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 60 | $ 60 |
Investments at fair value |  | $ 0 | $ 3 |
Number of Shares (in shares) |  | 147,361 | 147,361 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.00% |
Margin |  |  | 5.50% |
Floor |  |  | 11.00% |
Ceiling |  |  | 18.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Dec. 01, 2026 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,798 |
Investments at fair value |  |  | $ 4,798 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.00% |
Margin |  |  | 5.50% |
Floor |  |  | 11.00% |
Ceiling |  |  | 18.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Dec. 01, 2026 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,948 |
Investments at fair value |  |  | 4,948 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 6 |
Investments at fair value |  |  | $ 6 |
Number of Shares (in shares) |  |  | 86,300 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Everstream Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 70 |  |
Investments at fair value |  | $ 63 |  |
Number of Shares (in shares) |  | 350,000 |  |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Revinate Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 44 | $ 46 |
Investments at fair value |  | $ 91 | $ 99 |
Number of Shares (in shares) |  | 682,034 | 682,034 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Riv Data Corp [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 12 |
Investments at fair value |  |  | $ 296 |
Number of Shares (in shares) |  |  | 321,428 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | SIGNiX, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 225 | $ 225 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 186,235 | 186,235 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Skyword, Inc [Member] | Warrant [Member] |  |  |  |
Investments at cost |  |  | $ 48 |
Investments at fair value |  |  | $ 1 |
Number of Shares (in shares) |  |  | 301,055 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Supply Network Visiblity Holdings LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 64 |
Investments at fair value |  |  | $ 83 |
Number of Shares (in shares) |  |  | 682 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Topia Mobility, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 138 | $ 138 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 3,049,607 | 3,049,607 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | xAd, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 177 | $ 177 |
Investments at fair value |  | $ 5 | $ 12 |
Number of Shares (in shares) |  | 4,343,348 | 4,343,348 |
Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Branded Online, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  |  | $ 1,079 |
Investments at fair value |  |  | $ 83 |
Number of Shares (in shares) |  |  | 108,004 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 1.85% |
Maturity Date |  |  | Jul. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,951 |
Investments at fair value |  |  | $ 3,834 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 1.85% |
Maturity Date |  |  | Oct. 01, 2025 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,474 |
Investments at fair value |  |  | 1,916 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 26 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 10,690 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 11.25% | 11.25% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 11.25% | 11.25% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,608 | 3,478 |
Investments at fair value |  | $ 3,608 | $ 3,478 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 11.25% | 11.25% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 11.25% | 11.25% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 1,250 | $ 1,250 |
Investments at cost |  | 1,242 | 1,238 |
Investments at fair value |  | 1,242 | 1,238 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 94 | 56 |
Investments at fair value |  | $ 250 | $ 233 |
Number of Shares (in shares) |  | 37,282 | 31,966 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 11.25% | 11.25% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 11.25% | 11.25% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,726 | 3,715 |
Investments at fair value |  | $ 3,726 | $ 3,715 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 11.25% | 11.25% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 11.25% | 11.25% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 1,250 | $ 1,250 |
Investments at cost |  | 1,242 | 1,238 |
Investments at fair value |  | $ 1,242 | $ 1,238 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 11.25% | 11.25% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 11.25% | 11.25% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,726 | 3,715 |
Investments at fair value |  | $ 3,726 | $ 3,715 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 11.25% | 11.25% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 11.25% | 11.25% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2027 | Jul. 01, 2027 |
Principal Amount |  | $ 1,250 | $ 1,250 |
Investments at cost |  | 1,242 | 1,238 |
Investments at fair value |  | $ 1,242 | $ 1,238 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  | 11.25% | 11.25% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 11.25% | 11.25% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jan. 01, 2028 | Jan. 01, 2028 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,712 | 3,698 |
Investments at fair value |  | $ 3,712 | $ 3,698 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate |  | 11.25% | 11.25% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 11.25% | 11.25% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jan. 01, 2028 | Jan. 01, 2028 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,712 | 3,698 |
Investments at fair value |  | $ 3,712 | $ 3,698 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 6.00% |  |
Floor |  | 9.50% |  |
Ceiling |  | 11.25% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,706 |  |
Investments at fair value |  | $ 3,706 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 6.00% |  |
Floor |  | 9.50% |  |
Ceiling |  | 11.25% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Jul. 01, 2028 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,707 |  |
Investments at fair value |  | $ 3,707 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 6.00% |  |
Floor |  | 9.50% |  |
Ceiling |  | 11.25% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Jul. 01, 2028 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,707 |  |
Investments at fair value |  | $ 3,707 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.75% | 14.75% |
Margin |  | 7.25% | 7.25% |
Floor |  | 10.50% | 10.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 3,383 | $ 3,500 |
Investments at cost |  | 3,356 | 3,461 |
Investments at fair value |  | 3,356 | 3,461 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 22 | 20 |
Investments at fair value |  | $ 27 | $ 61 |
Number of Shares (in shares) |  | 75,997 | 17,605 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | Aug. 01, 2025 | Aug. 01, 2025 |
Principal Amount |  | $ 1,667 | $ 2,500 |
Investments at cost |  | 1,656 | 2,482 |
Investments at fair value |  | $ 1,656 | $ 2,482 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | Aug. 01, 2025 | Aug. 01, 2025 |
Principal Amount |  | $ 1,583 | $ 2,500 |
Investments at cost |  | 1,573 | 2,482 |
Investments at fair value |  | 1,573 | 2,482 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 29 | 30 |
Investments at fair value |  | $ 122 | $ 125 |
Number of Shares (in shares) |  | 46,745 | 46,745 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jan. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,966 |
Investments at fair value |  |  | $ 4,966 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jan. 01, 2025 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,966 |
Investments at fair value |  |  | 4,966 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 93 | 93 |
Investments at fair value |  | $ 0 | $ 64 |
Number of Shares (in shares) |  | 20,000 | 20,000 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jan. 01, 2025 |
Principal Amount |  |  | $ 3,000 |
Investments at cost |  |  | 2,979 |
Investments at fair value |  |  | $ 2,979 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Dec. 01, 2025 |
Principal Amount |  |  | $ 1,000 |
Investments at cost |  |  | 976 |
Investments at fair value |  |  | $ 976 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Feb. 01, 2026 |
Principal Amount |  |  | $ 1,000 |
Investments at cost |  |  | 977 |
Investments at fair value |  |  | 977 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Aterian, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 195 | 195 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 76,923 | 76,923 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Caastle, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 65 | $ 68 |
Investments at fair value |  | $ 1,055 | $ 1,069 |
Number of Shares (in shares) |  | 268,591 | 268,591 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.50% | 12.50% |
Margin |  | 5.00% | 5.00% |
Floor |  | 5.00% | 5.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Mar. 01, 2027 | Mar. 01, 2027 |
Principal Amount |  | $ 2,000 | $ 2,000 |
Investments at cost |  | 1,421 | 1,082 |
Investments at fair value |  | $ 1,421 | $ 1,082 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 13.50% | 12.50% |
Margin |  | 5.00% | 5.00% |
Floor |  | 5.00% | 5.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Mar. 01, 2027 | Mar. 01, 2027 |
Principal Amount |  | $ 3,000 | $ 3,000 |
Investments at cost |  | 2,131 | 1,623 |
Investments at fair value |  | 2,131 | 1,623 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 2,947 | 2,947 |
Investments at fair value |  | $ 2,259 | $ 2,947 |
Number of Shares (in shares) |  | 1,312,500 | 1,312,500 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.00% | 11.00% |
Margin |  | 3.50% | 3.50% |
Floor |  | 10.50% | 10.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 7.78% | 7.78% |
Maturity Date |  | Feb. 01, 2028 | Feb. 01, 2028 |
Principal Amount |  | $ 2,813 | $ 2,813 |
Investments at cost |  | 2,813 | 2,813 |
Investments at fair value |  | $ 2,813 | $ 2,813 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.00% | 11.00% |
Margin |  | 3.50% | 3.50% |
Floor |  | 10.50% | 10.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 7.78% | 7.78% |
Maturity Date |  | Feb. 01, 2028 | Feb. 01, 2028 |
Principal Amount |  | $ 2,813 | $ 2,813 |
Investments at cost |  | 2,813 | 2,813 |
Investments at fair value |  | $ 2,813 | $ 2,813 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.50% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jan. 01, 2026 |
Principal Amount |  |  | $ 3,210 |
Investments at cost |  |  | 3,151 |
Investments at fair value |  |  | $ 0 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.50% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jan. 01, 2026 |
Principal Amount |  |  | $ 2,963 |
Investments at cost |  |  | 2,886 |
Investments at fair value |  |  | 0 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 103 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 553,710 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Oct. 01, 2025 | Oct. 01, 2025 |
Principal Amount |  | $ 3,667 | $ 5,000 |
Investments at cost |  | 3,647 | 4,954 |
Investments at fair value |  | $ 3,647 | $ 4,954 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Oct. 01, 2025 | Oct. 01, 2025 |
Principal Amount |  | $ 1,833 | $ 2,500 |
Investments at cost |  | 1,824 | 2,477 |
Investments at fair value |  | 1,824 | 2,477 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 29 | 29 |
Investments at fair value |  | $ 56 | $ 37 |
Number of Shares (in shares) |  | 250 | 143 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Lyrical Foods, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.00% | 10.00% |
Margin |  | 3.50% | 6.75% |
Floor |  | 9.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 1.00% | 0.00% |
Maturity Date |  | Sep. 01, 2027 | Sep. 01, 2027 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,591 | 2,588 |
Investments at fair value |  | $ 2,429 | $ 2,279 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.25% | 2.00% |
Maturity Date |  | Oct. 31, 2023 | Dec. 30, 2022 |
Principal Amount |  | $ 5,752 | $ 5,000 |
Investments at cost |  | 5,752 | 4,943 |
Investments at fair value |  | $ 5,018 | $ 4,715 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.25% | 2.00% |
Maturity Date |  | Oct. 31, 2023 | Dec. 30, 2022 |
Principal Amount |  | $ 2,301 | $ 2,000 |
Investments at cost |  | 2,301 | 1,981 |
Investments at fair value |  | 2,007 | 1,890 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 188 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 12,618 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 9 | 197 |
Investments at fair value |  | $ 0 | $ 17 |
Number of Shares (in shares) |  | 1,224,752 | 1,261,253 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.25% | 2.00% |
Maturity Date |  | Oct. 31, 2023 | Dec. 30, 2022 |
Principal Amount |  | $ 2,876 | $ 2,500 |
Investments at cost |  | 2,876 | 2,477 |
Investments at fair value |  | $ 2,509 | $ 2,363 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.25% | 2.00% |
Maturity Date |  | Oct. 31, 2023 | Dec. 30, 2022 |
Principal Amount |  | $ 3,451 | $ 3,000 |
Investments at cost |  | 3,451 | 2,971 |
Investments at fair value |  | $ 3,011 | $ 2,835 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.25% | 2.00% |
Maturity Date |  | Oct. 31, 2023 | Dec. 30, 2022 |
Principal Amount |  | $ 2,876 | $ 2,500 |
Investments at cost |  | 2,876 | 2,459 |
Investments at fair value |  | $ 2,510 | $ 2,345 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.25% | 2.00% |
Maturity Date |  | Oct. 31, 2023 | Dec. 30, 2022 |
Principal Amount |  | $ 2,876 | $ 2,500 |
Investments at cost |  | 2,876 | 2,459 |
Investments at fair value |  | $ 2,510 | $ 2,345 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.25% | 2.00% |
Maturity Date |  | Oct. 31, 2023 | Dec. 30, 2022 |
Principal Amount |  | $ 5,752 | $ 5,000 |
Investments at cost |  | 5,752 | 4,914 |
Investments at fair value |  | $ 5,018 | $ 4,688 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate |  | 14.25% | 12.75% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.25% | 2.00% |
Maturity Date |  | Oct. 31, 2023 | Dec. 30, 2022 |
Principal Amount |  | $ 2,876 | $ 2,500 |
Investments at cost |  | 2,876 | 2,456 |
Investments at fair value |  | 2,510 | $ 2,342 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | CZV, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 81 |  |
Investments at fair value |  | $ 71 |  |
Number of Shares (in shares) |  | 65,569 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.75% | 13.25% |
Margin |  | 6.25% | 6.25% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Aug. 01, 2027 | Aug. 01, 2027 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,416 | 2,347 |
Investments at fair value |  | $ 2,416 | 2,347 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.75% |  |
Margin |  | 6.25% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jul. 01, 2028 |  |
Principal Amount |  | $ 1,875 |  |
Investments at cost |  | 1,787 |  |
Investments at fair value |  | 1,787 |  |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 182 | 104 |
Investments at fair value |  | $ 145 | $ 104 |
Number of Shares (in shares) |  | 11,550 | 6,600 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 7.25% |
Floor |  |  | 10.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Mar. 01, 2025 |
Principal Amount |  |  | $ 2,700 |
Investments at cost |  |  | 2,673 |
Investments at fair value |  |  | $ 2,673 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 7.25% |
Floor |  |  | 10.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Mar. 01, 2025 |
Principal Amount |  |  | $ 2,700 |
Investments at cost |  |  | 2,673 |
Investments at fair value |  |  | 2,673 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 57 | 57 |
Investments at fair value |  | $ 591 | $ 429 |
Number of Shares (in shares) |  | 553,778 | 553,778 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 7.25% |
Floor |  |  | 10.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Sep. 01, 2025 |
Principal Amount |  |  | $ 3,000 |
Investments at cost |  |  | 2,967 |
Investments at fair value |  |  | 2,967 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Quip NYC Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 325 | 325 |
Investments at fair value |  | $ 533 | $ 534 |
Number of Shares (in shares) |  | 6,191 | 6,191 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  |  | $ 253 |
Investments at fair value |  |  | $ 57 |
Number of Shares (in shares) |  |  | 87,082 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 16.25% | 15.25% |
Margin |  | 7.75% | 7.75% |
Floor |  | 11.00% | 11.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 0.00% | 0.00% |
Maturity Date |  | May 01, 2027 | Jul. 01, 2025 |
Principal Amount |  | $ 1,204 | $ 2,500 |
Investments at cost |  | 1,086 | 2,473 |
Investments at fair value |  | $ 872 | $ 2,473 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 16.25% | 15.25% |
Margin |  | 7.75% | 7.75% |
Floor |  | 11.00% | 11.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 0.00% | 0.00% |
Maturity Date |  | May 01, 2027 | Jul. 01, 2025 |
Principal Amount |  | $ 602 | $ 1,250 |
Investments at cost |  | 543 | 1,236 |
Investments at fair value |  | 436 | 1,236 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 32 | 32 |
Investments at fair value |  | $ 0 | $ 22 |
Number of Shares (in shares) |  | 171,081 | 171,081 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 16.25% | 15.25% |
Margin |  | 7.75% | 7.75% |
Floor |  | 11.00% | 11.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 0.00% | 0.00% |
Maturity Date |  | May 01, 2027 | Jul. 01, 2025 |
Principal Amount |  | $ 602 | $ 1,250 |
Investments at cost |  | 543 | 1,236 |
Investments at fair value |  | 436 | 1,236 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Updater, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 34 | 34 |
Investments at fair value |  | $ 0 | $ 42 |
Number of Shares (in shares) |  | 114,659 | 108,333 |
Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  |  | $ 8 |
Investments at fair value |  |  | $ 83 |
Number of Shares (in shares) |  |  | 82,974 |
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | $ 5,335 |  |
Investments at fair value |  | $ 4,969 |  |
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 1.85% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 3,547 |  |
Investments at cost |  | 3,585 |  |
Investments at fair value |  | $ 3,339 |  |
Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 1.85% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 1,773 |  |
Investments at cost |  | 1,750 |  |
Investments at fair value |  | 1,630 |  |
Other Sustainability Sector [Member] |  |  |  |
Investments at cost |  | 98,906 | $ 84,633 |
Investments at fair value |  | 80,370 | 85,524 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost |  | 999 |  |
Investments at fair value |  | $ 542 |  |
Number of Shares (in shares) |  |  |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | $ 250 |  |
Investments at fair value |  | $ 250 |  |
Number of Shares (in shares) |  | 1,162 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.33% |  |
Maturity Date |  | Dec. 01, 2026 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,685 |  |
Investments at fair value |  | $ 3,685 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 15.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.33% |  |
Maturity Date |  | Dec. 01, 2026 |  |
Principal Amount |  | $ 3,750 |  |
Investments at cost |  | 3,685 |  |
Investments at fair value |  | 3,685 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 81 |  |
Investments at fair value |  | $ 72 |  |
Number of Shares (in shares) |  | 400,000 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | LiquiGlide, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 39 | 39 |
Investments at fair value |  | $ 50 | $ 55 |
Number of Shares (in shares) |  | 61,359 | 61,539 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | $ 355 |  |
Investments at fair value |  | $ 355 |  |
Number of Shares (in shares) |  | 32,831 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 8,425 |  |
Investments at cost |  | 8,353 |  |
Investments at fair value |  | $ 4,549 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 8,425 |  |
Investments at cost |  | 8,229 |  |
Investments at fair value |  | 4,481 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | 490 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 215,171 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 8,425 |  |
Investments at cost |  | 8,229 |  |
Investments at fair value |  | $ 4,481 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 5,617 |  |
Investments at cost |  | 5,480 |  |
Investments at fair value |  | $ 2,984 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 5,617 |  |
Investments at cost |  | 5,480 |  |
Investments at fair value |  | $ 2,984 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 735 |  |
Investments at cost |  | 726 |  |
Investments at fair value |  | $ 395 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 586 |  |
Investments at cost |  | 578 |  |
Investments at fair value |  | $ 315 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 292 |  |
Investments at cost |  | 288 |  |
Investments at fair value |  | $ 157 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 290 |  |
Investments at cost |  | 286 |  |
Investments at fair value |  | $ 156 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 174 |  |
Investments at cost |  | 172 |  |
Investments at fair value |  | $ 93 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 802 |  |
Investments at cost |  | 791 |  |
Investments at fair value |  | $ 431 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Prime Index, Twelve [Member] |  |  |  |
Cash Rate |  | 15.50% |  |
Margin |  | 7.00% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Mar. 31, 2024 |  |
Principal Amount |  | $ 1,091 |  |
Investments at cost |  | 1,083 |  |
Investments at fair value |  | $ 590 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.75% | 2.75% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 2,500 |
Investments at cost |  | 4,959 | 2,463 |
Investments at fair value |  | $ 4,959 | $ 2,463 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.75% | 2.75% |
Maturity Date |  | Apr. 01, 2026 | Apr. 01, 2026 |
Principal Amount |  | $ 2,500 | $ 5,000 |
Investments at cost |  | 2,479 | 4,927 |
Investments at fair value |  | 2,479 | 4,927 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 214 | 214 |
Investments at fair value |  | $ 340 | $ 361 |
Number of Shares (in shares) |  | 681 | 681 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.75% | 2.75% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,956 | 4,924 |
Investments at fair value |  | $ 4,956 | $ 4,924 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.75% | 2.75% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,478 | 2,462 |
Investments at fair value |  | $ 2,478 | $ 2,462 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 11.75% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.75% | 2.75% |
Maturity Date |  | Dec. 01, 2026 | Dec. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,934 | 4,900 |
Investments at fair value |  | $ 4,934 | $ 4,900 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 14.00% | 13.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 11.75% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.75% | 2.75% |
Maturity Date |  | Dec. 01, 2026 | Dec. 01, 2026 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,467 | 2,450 |
Investments at fair value |  | $ 2,467 | $ 2,450 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Apr. 01, 2028 | Jun. 01, 2025 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,694 | 3,697 |
Investments at fair value |  | $ 3,694 | $ 3,697 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Apr. 01, 2028 | Jun. 01, 2025 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,694 | 3,717 |
Investments at fair value |  | 3,694 | 3,717 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 175 | 126 |
Investments at fair value |  | $ 80 | $ 268 |
Number of Shares (in shares) |  | 46,311 | 35,906 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Apr. 01, 2028 | Oct. 01, 2025 |
Principal Amount |  | $ 7,500 | $ 7,500 |
Investments at cost |  | 7,379 | 7,424 |
Investments at fair value |  | $ 7,379 | $ 7,424 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Apr. 01, 2028 | Oct. 01, 2025 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,690 | 3,712 |
Investments at fair value |  | $ 3,690 | $ 3,712 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 15.25% | 14.25% |
Margin |  | 6.75% | 6.75% |
Floor |  | 10.00% | 10.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 2.50% | 2.50% |
Maturity Date |  | Apr. 01, 2028 | Oct. 01, 2025 |
Principal Amount |  | $ 3,750 | $ 3,750 |
Investments at cost |  | 3,690 | 3,712 |
Investments at fair value |  | $ 3,690 | 3,712 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 14.50% |  |
Margin |  | 6.00% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 4,500 |  |
Investments at cost |  | 4,446 |  |
Investments at fair value |  | $ 4,446 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  | 14.50% |  |
Margin |  | 6.00% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 2,000 |  |
Investments at cost |  | 1,976 |  |
Investments at fair value |  | 1,976 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | 2,000 |  |
Investments at fair value |  | $ 1,700 |  |
Number of Shares (in shares) |  | 392,651 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Cadrenal Therapeutics, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | $ 0 |  |
Investments at fair value |  | $ 443 |  |
Number of Shares (in shares) |  | 600,000 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | $ 253 |  |
Investments at fair value |  | $ 20 |  |
Number of Shares (in shares) |  | 87,082 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | $ 9 |  |
Investments at fair value |  | $ 83 |  |
Number of Shares (in shares) |  | 82,974 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | $ 111 |  |
Investments at fair value |  | $ 13 |  |
Number of Shares (in shares) |  | 5,205 |  |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost |  |  | 8 |
Investments at fair value |  |  | $ 27 |
Number of Shares (in shares) |  |  | 22,313 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 3,750 |
Investments at cost |  |  | 3,699 |
Investments at fair value |  |  | $ 3,699 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 3,750 |
Investments at cost |  |  | 3,699 |
Investments at fair value |  |  | 3,699 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 61 |
Investments at fair value |  |  | $ 74 |
Number of Shares (in shares) |  |  | 201,537 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Sep. 01, 2025 |
Principal Amount |  |  | $ 7,500 |
Investments at cost |  |  | 7,371 |
Investments at fair value |  |  | $ 7,371 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Sep. 01, 2025 |
Principal Amount |  |  | $ 7,500 |
Investments at cost |  |  | 7,371 |
Investments at fair value |  |  | 7,371 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 488 |
Investments at fair value |  |  | $ 1,061 |
Number of Shares (in shares) |  |  | 204,832 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Sep. 01, 2025 |
Principal Amount |  |  | $ 7,500 |
Investments at cost |  |  | 7,371 |
Investments at fair value |  |  | $ 7,371 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jul. 01, 2026 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,903 |
Investments at fair value |  |  | $ 4,903 |
Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jul. 01, 2026 |
Principal Amount |  |  | $ 5,000 |
Investments at cost |  |  | 4,903 |
Investments at fair value |  |  | 4,903 |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | $ 69,770 |  |
Investments at fair value |  | 69,770 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost |  | 966 |  |
Investments at fair value |  | 1,871 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 46 |  |
Investments at fair value |  | $ 12 |  |
Number of Shares (in shares) |  | 171,370 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 70 |  |
Investments at fair value |  | $ 70 |  |
Number of Shares (in shares) |  | 32,244 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 166 |  |
Investments at fair value |  | $ 166 |  |
Number of Shares (in shares) |  | 184,253 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 102 |  |
Investments at fair value |  | $ 1,366 |  |
Number of Shares (in shares) |  | 82,965 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 167 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 85,066 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 192 |  |
Investments at fair value |  | $ 99 |  |
Number of Shares (in shares) |  | 652,250 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 60 |  |
Investments at fair value |  | $ 108 |  |
Number of Shares (in shares) |  | 7,097,792 |  |
Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 163 |  |
Investments at fair value |  | $ 50 |  |
Number of Shares (in shares) |  | 150,353 |  |
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | $ 275,026 | 268,468 |
Investments at fair value |  | 269,790 | 259,366 |
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost |  | 9,733 | 9,249 |
Investments at fair value |  | 14,506 | 16,148 |
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member] |  |  |  |
Investments at cost |  | 3,311 |  |
Investments at fair value |  | 3,024 |  |
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Common Stock [Member] |  |  |  |
Investments at cost |  | 2,061 |  |
Investments at fair value |  | $ 2,165 |  |
Number of Shares (in shares) |  | 2,278,272 |  |
Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost |  | $ 1,250 |  |
Investments at fair value |  | $ 859 |  |
Number of Shares (in shares) |  | 3,124,448 |  |
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | $ 249,642 | 318,172 |
Investments at fair value |  | 244,815 | 317,568 |
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost |  |  | 4,197 |
Investments at fair value |  |  | $ 9,792 |
Number of Shares (in shares) |  |  |  |
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Other Investments [Member] |  |  |  |
Investments at cost |  | 1,200 |  |
Investments at fair value |  | 200 |  |
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost |  | 1,200 |  |
Investments at fair value |  | 200 |  |
Life Science [Member] | Investment, Unaffiliated Issuer [Member] | ZetrOZ, Inc [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost |  | 0 |  |
Investments at fair value |  | 0 |  |
Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | 23,551 |  |
Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] |  |  |  |
Investments at cost |  | 5,000 |  |
Investments at fair value |  | $ 132 |  |
Number of Shares (in shares) |  |  |  |
Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] |  |  |  |
Investments at cost |  | $ 5,782 |  |
Investments at fair value |  | 6,230 |  |
Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Other Investments [Member] |  |  |  |
Investments at cost |  | 5,782 |  |
Investments at fair value |  | 6,230 |  |
Data Storage Sector [Member] |  |  |  |
Investments at cost |  | 417 | $ 476 |
Investments at fair value |  | 418 | 1,316 |
Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | CPG Beyond, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 242 | 242 |
Investments at fair value |  | $ 294 | $ 909 |
Number of Shares (in shares) |  | 500,000 | 500,000 |
Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Silk, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 175 | $ 234 |
Investments at fair value |  | $ 124 | $ 407 |
Number of Shares (in shares) |  | 394,110 | 442,110 |
Internet and Media Sector [Member] |  |  |  |
Investments at cost |  | $ 329 | $ 329 |
Investments at fair value |  | 1,582 | 1,159 |
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Global Worldwide LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 75 | 75 |
Investments at fair value |  | $ 63 | $ 0 |
Number of Shares (in shares) |  | 245,810 | 245,810 |
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Rocket Lawyer Incorporated [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 92 | $ 92 |
Investments at fair value |  | $ 318 | $ 357 |
Number of Shares (in shares) |  | 261,721 | 261,721 |
Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Skillshare, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | $ 162 | $ 162 |
Investments at fair value |  | $ 1,201 | $ 802 |
Number of Shares (in shares) |  | 139,074 | 139,074 |
Networking Sector [Member] |  |  |  |
Investments at cost |  | $ 5,451 | $ 11,831 |
Investments at fair value |  | $ 5,297 | $ 11,710 |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.75% | 13.25% |
Margin |  | 6.25% | 6.25% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Sep. 01, 2024 | Sep. 01, 2024 |
Principal Amount |  | $ 1,500 | $ 3,333 |
Investments at cost |  | 1,481 | 3,286 |
Investments at fair value |  | $ 1,481 | $ 3,286 |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.75% | 13.25% |
Margin |  | 6.25% | 6.25% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Sep. 01, 2024 | Sep. 01, 2024 |
Principal Amount |  | $ 1,500 | $ 3,333 |
Investments at cost |  | 1,481 | 3,286 |
Investments at fair value |  | 1,481 | 3,286 |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 364 | 364 |
Investments at fair value |  | $ 210 | $ 243 |
Number of Shares (in shares) |  | 344,102 | 344,102 |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.75% | 13.25% |
Margin |  | 6.25% | 6.25% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Sep. 01, 2024 | Sep. 01, 2024 |
Principal Amount |  | $ 750 | $ 1,667 |
Investments at cost |  | 740 | 1,641 |
Investments at fair value |  | $ 740 | $ 1,641 |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 14.75% | 13.25% |
Margin |  | 6.25% | 6.25% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Sep. 01, 2024 | Sep. 01, 2024 |
Principal Amount |  | $ 667 | $ 1,667 |
Investments at cost |  | 656 | 1,641 |
Investments at fair value |  | $ 656 | $ 1,641 |
Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 14.75% | 13.25% |
Margin |  | 6.25% | 6.25% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Sep. 01, 2024 | Sep. 01, 2024 |
Principal Amount |  | $ 750 | $ 1,667 |
Investments at cost |  | 729 | 1,613 |
Investments at fair value |  | 729 | 1,613 |
Power Management Sector [Member] |  |  |  |
Investments at cost |  | 1,585 | 1,585 |
Investments at fair value |  | 2,700 | 2,610 |
Power Management Sector [Member] | Investment, Unaffiliated Issuer [Member] | Halio, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  | 1,585 | 1,585 |
Investments at fair value |  | $ 2,700 | $ 2,610 |
Number of Shares (in shares) |  | 38,241,466 | 5,002,574 |
Semiconductor Sector [Member] |  |  |  |
Investments at cost |  | $ 45 | $ 56 |
Investments at fair value |  | 0 | 0 |
Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalanche Technology, Inc [Member] | Warrant [Member] |  |  |  |
Investments at cost |  |  | 56 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 6,081 |
Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member] | Avalanche Technology, Inc [Member] | Preferred and Common Stock [Member] |  |  |  |
Investments at cost |  | 45 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 5,938 |  |
Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost |  | $ 4,702 |  |
Investments at fair value |  | 7,675 |  |
Diagnostics Sector [Member] |  |  |  |
Investments at cost |  | 19,735 | $ 9,851 |
Investments at fair value |  | $ 19,701 | $ 9,858 |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.50% | 13.50% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.50% | 3.50% |
Maturity Date |  | Jun. 01, 2026 | Jun. 01, 2026 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,484 | 2,385 |
Investments at fair value |  | $ 2,484 | $ 2,385 |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.50% | 13.50% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.50% | 3.50% |
Maturity Date |  | Jun. 01, 2026 | Jun. 01, 2026 |
Principal Amount |  | $ 2,500 | $ 2,500 |
Investments at cost |  | 2,484 | 2,473 |
Investments at fair value |  | $ 2,484 | 2,473 |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 47 |
Investments at fair value |  |  | $ 54 |
Number of Shares (in shares) |  |  | 159,893 |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.50% | 13.50% |
Margin |  | 6.00% | 6.00% |
Floor |  | 9.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.50% | 3.50% |
Maturity Date |  | Jun. 01, 2026 | Jun. 01, 2026 |
Principal Amount |  | $ 5,000 | $ 5,000 |
Investments at cost |  | 4,968 | 4,946 |
Investments at fair value |  | $ 4,968 | 4,946 |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.25% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,633 |  |
Investments at fair value |  | $ 4,633 |  |
Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.25% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,884 |  |
Investments at fair value |  | 4,884 |  |
Software, Healthcare Information and Service [Member] |  |  |  |
Investments at cost |  | 50,899 | 13,735 |
Investments at fair value |  | $ 50,574 | $ 14,044 |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.00% | 12.50% |
Margin |  | 5.50% | 5.50% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Aug. 01, 2027 | Aug. 01, 2027 |
Principal Amount |  | $ 7,000 | $ 7,000 |
Investments at cost |  | 6,684 | 6,619 |
Investments at fair value |  | $ 6,684 | $ 6,619 |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 14.00% | 12.50% |
Margin |  | 5.50% | 5.50% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Aug. 01, 2027 | Aug. 01, 2027 |
Principal Amount |  | $ 3,500 | $ 3,500 |
Investments at cost |  | 3,463 | 3,448 |
Investments at fair value |  | $ 3,463 | 3,448 |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 160 |
Investments at fair value |  |  | $ 170 |
Number of Shares (in shares) |  |  | 80,544 |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 14.00% | 12.50% |
Margin |  | 5.50% | 5.50% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Aug. 01, 2027 | Aug. 01, 2027 |
Principal Amount |  | $ 3,500 | $ 3,500 |
Investments at cost |  | 3,463 | 3,448 |
Investments at fair value |  | $ 3,463 | 3,448 |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 2,750 |  |
Investments at cost |  | 2,710 |  |
Investments at fair value |  | $ 2,710 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2027 |  |
Principal Amount |  | $ 10,000 |  |
Investments at cost |  | 9,656 |  |
Investments at fair value |  | $ 9,656 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,925 |  |
Investments at fair value |  | $ 4,925 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,925 |  |
Investments at fair value |  | $ 4,925 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,925 |  |
Investments at fair value |  | $ 4,925 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 60 |
Investments at fair value |  |  | $ 359 |
Number of Shares (in shares) |  |  | 7,097,792 |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,648 |  |
Investments at fair value |  | $ 4,648 |  |
Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 5,000 |  |
Investments at cost |  | 4,918 |  |
Investments at fair value |  | 4,918 |  |
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | 97,907 | $ 83,705 |
Investments at fair value |  | 79,828 | 83,705 |
Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost |  |  | 928 |
Investments at fair value |  |  | $ 1,819 |
Number of Shares (in shares) |  |  |  |
Other Healthcare Sector [Member] |  |  |  |
Investments at cost |  | 102 | $ 7,559 |
Investments at fair value |  | $ 1,366 | 3,870 |
Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 102 |
Investments at fair value |  |  | $ 1,370 |
Number of Shares (in shares) |  |  | 82,965 |
Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2025 |
Principal Amount |  |  | $ 4,943 |
Investments at cost |  |  | 4,943 |
Investments at fair value |  |  | $ 1,668 |
Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Dec. 31, 2025 |
Principal Amount |  |  | $ 2,500 |
Investments at cost |  |  | 2,467 |
Investments at fair value |  |  | 832 |
Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 47 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 77,690 |
Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  |  | $ 30,729 |
Investments at fair value |  |  | 25,819 |
Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost |  |  | 416 |
Investments at fair value |  |  | $ 1,953 |
[1] | As of December 31, 2023, the Company no longer owns 5% of more of the portfolio company.

X
- Definition The ceiling rate of the investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedCeilingRate
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The end of term payment rate (ETP) on investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CorviumIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_FstarTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImvIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketPharmaceuticalsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VtvTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CorinthMedtechIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmbodyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ZetrozIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CvrxIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MicroTransponderIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_ConvertibleDebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_Engage3LLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ReputationInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GroundspeedAnalyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RivDataCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkywordIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrandedOnlineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexElevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AterianIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InteriorDefineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CZVIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwelveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsInc1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_HealthcareInformationAndServicesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ParseBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DataStorageSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_InternetAndMediaSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_PowerManagementSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HalioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SemiconductorSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredAndCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareHealthcareInformationAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SecureTransfusionServicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_HealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |